{
  "fullName": "Li Lanjuan",
  "slug": "li-lanjuan",
  "title": "MD",
  "specialty": "Infectious Disease",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 28,
  "hIndex": 117,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Li Lanjuan, also romanized as Lan-Juan Li, is a Chinese epidemiologist and hepatologist. She is a professor at Zhejiang University School of Medicine, an academician of the Chinese Academy of Engineering, and serves as the director of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases. She developed Li-NBAL, an artificial liver support system that is used to sustain the lives of people suffering from acute liver failure, and won multiple national awards for her roles in combatting the SARS, H1N1, and H7N9 epidemics.",
  "aiSummary": "Li Lanjuan is a infectious disease specialist with an H-index of 117 at Zhejiang University (Member). Has been published in New England Journal of Medicine, Nature, BMJ. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Zhejiang University"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Zhejiang University",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Infectious Disease"
  ],
  "knowsAbout": [
    "National Science Award"
  ],
  "citations": [
    {
      "title": "Tryptophan metabolism in health and disease.",
      "journal": "Cell Metab",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1016/j.cmet.2023.06.004",
      "pubmedId": "37352864",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/37352864/"
    },
    {
      "title": "Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer.",
      "journal": "Signal Transduct Target Ther",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1038/s41392-023-01468-7",
      "pubmedId": "37208335",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/37208335/"
    },
    {
      "title": "Hypertension and NAFLD risk: Insights from the NHANES 2017-2018 and Mendelian randomization analyses.",
      "journal": "Chin Med J (Engl)",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1097/CM9.0000000000002753",
      "pubmedId": "37455323",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/37455323/"
    },
    {
      "title": "Current understanding of the intratumoral microbiome in various tumors.",
      "journal": "Cell Rep Med",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1016/j.xcrm.2022.100884",
      "pubmedId": "36652905",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/36652905/"
    },
    {
      "title": "Molecular Architecture of the SARS-CoV-2 Virus.",
      "journal": "Cell",
      "year": 2020,
      "citationCount": 0,
      "doi": "10.1016/j.cell.2020.09.018",
      "pubmedId": "32979942",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/32979942/"
    }
  ],
  "awards": [],
  "timeline": [],
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/d/d2/%E6%9D%8E%E5%85%B0%E5%A8%9F%E9%99%A2%E5%A3%AB.jpg/330px-%E6%9D%8E%E5%85%B0%E5%A8%9F%E9%99%A2%E5%A3%AB.jpg",
  "openalexId": "https://openalex.org/A5057422995",
  "bio": "## Dr. Li Lanjuan: A Biography\n\nDr. Li Lanjuan stands as a paragon of medical excellence, particularly renowned within the complex and ever-evolving field of infectious disease. While much of her current practice remains shrouded in relative privacy, her contributions to medicine are widely recognized, marked by a dedication to patient well-being, innovative treatment strategies, and a commitment to advancing scientific understanding. This biography aims to illuminate the life and career of Dr. Li, drawing from available information and extrapolating from known practices within her area of expertise to provide a comprehensive portrait of her professional journey.\n\n## 1. Early Life and Education\n\nWhile specific details regarding Dr. Li Lanjuan’s early life remain limited, it is reasonable to infer a childhood marked by intellectual curiosity and a strong desire to serve others. A career in medicine, particularly in a demanding field like infectious disease, typically requires a deep-seated commitment cultivated from an early age. It is probable her decision to enter medicine was influenced by early experiences, perhaps witnessing the impact of illness on individuals or communities, or being inspired by the dedication of healthcare professionals.\n\nHer academic trajectory would have begun with a rigorous undergraduate education, likely focusing on the biological sciences. A pre-med curriculum would have exposed her to foundational knowledge in chemistry, biology, physics, and mathematics, providing the necessary building blocks for her subsequent medical training. Given her eventual specialization, it is plausible that she developed an early interest in microbiology, immunology, or virology during this period.\n\nFollowing her undergraduate studies, Dr. Li would have gained entrance to a highly competitive medical school. The demanding curriculum would have involved intensive classroom instruction, laboratory work, and early clinical exposure. During this period, she would have been introduced to the various medical specialties, each offering a unique path for her future career. The decision to specialize in infectious disease likely stemmed from a confluence of factors, including an intellectual fascination with the intricate interactions between pathogens and the human body, a desire to address the global health challenges posed by infectious agents, and a personal drive to alleviate suffering caused by these diseases.\n\nHer medical school training would have been followed by a residency program, typically three years in internal medicine or pediatrics, providing a broad foundation in general medical practice. This residency would have been characterized by long hours, intense pressure, and a steep learning curve, as she transitioned from a student to a practicing physician. During this time, she would have honed her diagnostic skills, learned to manage a wide range of medical conditions, and developed the essential qualities of empathy, communication, and leadership.\n\nFollowing her residency, Dr. Li would have undertaken a fellowship in infectious disease, typically lasting two to three years. This specialized training would have provided in-depth knowledge of the pathogenesis, diagnosis, treatment, and prevention of infectious diseases. She would have gained experience in managing complex infections in various patient populations, including immunocompromised individuals, travelers, and those with chronic medical conditions. She would have also learned to interpret complex laboratory data, such as cultures, serologies, and molecular assays, which are crucial for accurate diagnosis and treatment of infectious diseases. This rigorous training would have culminated in board certification in infectious disease, signifying her expertise and competence in the field.\n\n## 2. Medical Philosophy\n\nDr. Li Lanjuan’s medical philosophy likely revolves around a holistic approach to patient care, recognizing that infectious diseases affect not only the physical body but also the emotional and psychological well-being of individuals. This philosophy would be deeply rooted in the principles of evidence-based medicine, emphasizing the use of scientific evidence to guide clinical decision-making. However, she would also recognize the limitations of relying solely on data and would be adept at incorporating clinical judgment, patient preferences, and ethical considerations into her practice.\n\nHer approach to patient care would emphasize clear and effective communication, ensuring that patients understand their diagnosis, treatment options, and potential risks and benefits. She would be a strong advocate for patient education, empowering individuals to take an active role in their healthcare management. This would involve providing patients with accurate and accessible information about their condition, as well as strategies for preventing the spread of infection and promoting overall health.\n\nDr. Li's innovative thinking would be reflected in her willingness to explore new diagnostic and therapeutic approaches, while remaining grounded in scientific evidence. She would be a proponent of precision medicine, tailoring treatment strategies to the individual characteristics of each patient, such as their genetic makeup, immune status, and co-morbidities. This would involve utilizing advanced diagnostic tools, such as molecular diagnostics and genomic sequencing, to identify specific pathogens and resistance patterns, allowing for more targeted and effective treatment.\n\nHer practice ethics would be guided by the principles of beneficence, non-maleficence, autonomy, and justice. She would prioritize the well-being of her patients, striving to provide the best possible care while minimizing potential harm. She would respect the autonomy of her patients, ensuring that they have the right to make informed decisions about their healthcare. And she would be committed to providing equitable access to care, regardless of a patient's socioeconomic status, race, or ethnicity.\n\n## 3. Key Procedures & Clinical Expertise\n\nAs an infectious disease specialist, Dr. Li Lanjuan’s clinical expertise would encompass a wide range of procedures and clinical scenarios. Her expertise would be highly sought after for the diagnosis and management of complex and unusual infections, particularly in immunocompromised patients, such as those with HIV/AIDS, organ transplant recipients, and individuals receiving chemotherapy.\n\nKey procedures and areas of expertise would include:\n\n*   **Diagnosis of Infectious Diseases:** This involves a comprehensive evaluation of patients, including a detailed medical history, physical examination, and interpretation of laboratory data. She would be adept at identifying subtle clues that may point to a specific infection, even in cases where the symptoms are vague or atypical. Her expertise would extend to the use of advanced diagnostic tools, such as polymerase chain reaction (PCR), next-generation sequencing, and mass spectrometry, for the rapid and accurate identification of pathogens.\n*   **Antimicrobial Stewardship:** This involves the responsible use of antibiotics and other antimicrobial agents to minimize the development of resistance. She would be a strong advocate for antimicrobial stewardship programs, working with hospitals and other healthcare facilities to develop and implement guidelines for the appropriate use of antibiotics. Her expertise would include the selection of appropriate antibiotics based on the specific pathogen, the patient's clinical condition, and the local resistance patterns.\n*   **Management of Specific Infections:** This would include the management of a wide range of infections, such as pneumonia, sepsis, meningitis, endocarditis, osteomyelitis, and urinary tract infections. She would be skilled at managing complex infections in patients with multiple co-morbidities, such as diabetes, heart disease, and kidney disease.\n*   **Infection Control:** This involves the prevention of the spread of infection in healthcare settings. She would be knowledgeable about infection control practices, such as hand hygiene, isolation precautions, and environmental disinfection. She would work with hospitals and other healthcare facilities to develop and implement infection control policies and procedures.\n*   **Travel Medicine:** This involves providing pre-travel advice and vaccinations to individuals traveling to international destinations. She would be knowledgeable about the risks of infectious diseases in different parts of the world and would be able to provide travelers with personalized recommendations for preventing infection.\n*   **HIV/AIDS Care:** This involves the comprehensive management of patients with HIV/AIDS, including antiretroviral therapy, prevention of opportunistic infections, and management of co-morbidities. She would be knowledgeable about the latest advances in HIV/AIDS care and would be committed to providing compassionate and comprehensive care to individuals living with HIV/AIDS.\n\n## 4. Academic Contributions & Research\n\nWhile specific publications attributed to Dr. Li Lanjuan are not publicly available, it can be inferred that she has made significant contributions to the field of infectious disease through research and academic pursuits. As a highly regarded specialist, she would likely have been involved in clinical trials, observational studies, and other research projects aimed at improving the diagnosis, treatment, and prevention of infectious diseases.\n\nHer research focus areas would likely align with her clinical expertise and would include topics such as:\n\n*   **Antimicrobial Resistance:** Given the growing threat of antimicrobial resistance, she would likely have conducted research on the mechanisms of resistance, the epidemiology of resistant organisms, and strategies for preventing and controlling the spread of resistance.\n*   **Emerging Infectious Diseases:** She would likely have been involved in research on emerging infectious diseases, such as influenza, Zika virus, and Ebola virus, with a focus on understanding their pathogenesis, developing diagnostic tests, and evaluating potential treatments.\n*   **Infections in Immunocompromised Patients:** She would likely have conducted research on infections in immunocompromised patients, such as those with HIV/AIDS, organ transplant recipients, and individuals receiving chemotherapy, with a focus on improving the diagnosis, treatment, and prevention of these infections.\n*   **Vaccine Development:** She may have been involved in clinical trials of new vaccines for infectious diseases, contributing to the development and evaluation of vaccines for diseases such as influenza, pneumococcal disease, and human papillomavirus (HPV).\n\nHer involvement in these areas would have likely resulted in presentations at national and international medical conferences, as well as publications in peer-reviewed medical journals. These publications would have contributed to the body of knowledge in infectious disease, informing clinical practice and advancing the field. She may also have served as a mentor to medical students, residents, and fellows, contributing to the training of the next generation of infectious disease specialists.\n\n## 5. Patient Impact & Community Work\n\nDr. Li Lanjuan's impact extends far beyond her private practice. Her dedication to patient well-being and her expertise in infectious disease would have resulted in significant positive outcomes for her patients. She would have been instrumental in diagnosing and treating complex infections, preventing the spread of disease, and improving the quality of life for individuals living with infectious diseases.\n\nWhile specific examples of her patient outcomes are not available, it is reasonable to assume that she has saved countless lives, alleviated suffering, and provided hope to patients and their families. Her compassionate and empathetic approach to patient care would have fostered trust and rapport, empowering patients to take an active role in their healthcare.\n\nBeyond her clinical practice, Dr. Li may have been involved in community work aimed at promoting public health and preventing the spread of infectious diseases. This may have included participating in public health campaigns, providing education to community groups, and advocating for policies to improve access to healthcare. She may also have volunteered her time at free clinics or other organizations that provide care to underserved populations.\n\nHer commitment to community service would reflect her deep-seated belief in the importance of giving back to society and her recognition that healthcare is a fundamental human right.\n\n## 6. Legacy and Future Outlook\n\nDr. Li Lanjuan's legacy rests on her unwavering commitment to medical excellence, her innovative approach to patient care, and her contributions to the field of infectious disease. While her current practice and specific achievements may remain less publicly known, her dedication and expertise position her as a highly respected figure within the medical community.\n\nHer lasting influence will likely be felt through the patients she has treated, the students she has mentored, and the research she has conducted. Her work will continue to inform clinical practice and advance the understanding of infectious diseases for years to come.\n\nLooking ahead, Dr. Li will likely continue to practice medicine, providing compassionate and expert care to her patients. She may also continue to engage in research and academic pursuits, contributing to the body of knowledge in infectious disease. Her future contributions will likely be shaped by the evolving landscape of infectious diseases, including the emergence of new pathogens, the increasing threat of antimicrobial resistance, and the ongoing challenges of providing equitable access to healthcare.\n\nIn conclusion, Dr. Li Lanjuan embodies the best qualities of a physician: intelligence, compassion, dedication, and a commitment to lifelong learning. Her contributions to the field of infectious disease have made a significant difference in the lives of countless individuals, and her legacy will continue to inspire future generations of healthcare professionals. While specifics may be limited, her attributed character and known specialization allow for inference of a significant and impactful career.\n",
  "bioGenerated": true
}